Bristol-Myers Squibb Co
NYSE : BMY$59.75−1.27%Oct 16 close
Financials
CONSOLIDATED BALANCE SHEETS
USD · reported units. Click a value to inspect its source.
| Reported line item | Jun 30, 2026 (current) | Dec 31, 2025 |
|---|---|---|
| Statement of Financial Position [Abstract] | ||
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | ||
| Marketable debt securities | ||
| Receivables | ||
| Inventories | ||
| Other current assets | ||
| Total Current assets | ||
| Property, plant and equipment | ||
| Goodwill | ||
| Other intangible assets | ||
| Deferred income taxes | ||
| Marketable debt securities | ||
| Other non-current assets | ||
| Total Assets | ||
| LIABILITIES | ||
| Current liabilities: | ||
| Short-term debt obligations | ||
| Accounts payable | ||
| Other current liabilities | ||
| Total Current liabilities | ||
| Deferred income taxes | ||
| Long-term debt | ||
| Other non-current liabilities | ||
| Total Liabilities | ||
| Commitments and Contingencies (see Note 18) | — | — |
| EQUITY | ||
| BMS Shareholders’ equity: | ||
| Preferred stock | ||
| Common stock | ||
| Capital in excess of par value of stock | ||
| Accumulated other comprehensive loss | ||
| Retained earnings | ||
| Less cost of treasury stock | ||
| Total BMS Shareholders’ equity | ||
| Noncontrolling interest | ||
| Total Equity | ||
| Total Liabilities and Equity |
32 line items · 2 reported periodsOriginal filing order · parentheses indicate negative amounts
Each column reflects this filing’s presentation. Original line items and period dates are preserved.
Arithmetic validation is incomplete for this statement. Source values remain individually inspectable.